Status
Conditions
Treatments
About
This observational study is a large-scale, prospective, and multi-institutional observational study.
Patients from 19 to 75 years of age, will take a self-assessment (PRO) during the study period before and after administration of Pexuclue tablet.
Full description
Data will be collected based on patient's medical records from daily visit. Enrolled subjects will take a Patient Reported Outcome (PRO) survey including Quality of life evaluation (GERD-HRQL) and self-awareness symptom (RDQ).
The survey will be done twice (before and after the administration of Fexuclue tablet) electronically through an application (e-PRO).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
A person who falls under the prohibition of administration according to the permission for Fexuclue Tablet
A person who has taken a treatment for gastroesophageal reflux disease within two weeks from baseline visit.
In addition to the above, a person who has determined that the researcher (the doctor in charge) is not suitable for participation in this observation study
Loading...
Central trial contact
So Heui Kim
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal